View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, Jan. 25 (HealthDay News) -- According to a Jan. 21 press release issued by the U.S. Food and Drug Administration, the Nipro Medical Corporation has voluntarily recalled all of its GlucoPro Insulin Syringes because of a defect that may cause the needle to detach from the syringe, resulting in its being stuck in the insulin vial, pushed back into the syringe, or lodged in the patient's skin.
The recall includes all GlucoPro Insulin Syringe product codes and lot numbers with expiration dates before Nov. 1, 2011, distributed throughout the United States and Puerto Rico. The recall does not include the GlucoPro syringe that is used with the Amigo Insulin pump.
The FDA said that no injuries have been reported from the defective syringes to date, and that the company is in the process of notifying its distributors and customers and arranging for the return of all recalled products.
"Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax," according to the press release.
FDA MedWatch Adverse Event Reporting
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top